Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants

Mathew et al.
Papers
Scientific Reports
May 2018
Authors and Affiliates
James M. Mathew1,2, Jessica H.-Voss1, Ann LeFever3, Iwona Konieczna1, Cheryl Stratton3, Jie He1, Xuemei Huang1, Lorenzo Gallon1,4, Anton Skaro1, Mohammed Javeed Ansari1,4 & Joseph R. Leventhal1,5 1Department of Surgery, Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. 2Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. 3Mathews Center for Cellular Therapy, Northwestern Memorial Hospital, Chicago, IL, 60611, USA. 4Department of Medicine, Division of Nephrology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. 5TRACT Therapeutics, Inc; 125W. Oak Street; Suite D, Chicago, IL, 60610, USA.